Delivery Order SPE2DB22D3301-SPE2DB24FY7PK
- Not listed
- This is a $12,433.40 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 230-21 mcg inhalers, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a $8,600.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 mcg inhalers, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The 12-gram inhalers are scheduled for delivery by June 10, 2025. This award is not a set-aside contract, indicating open competition....
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Advair HFA 230-21 mcg inhalers, a prescription medication used to treat asthma and chronic obstructive pulmonary disease. The award has a ceiling value of $16,157.90 and an ultimate completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a $1,068.57 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Advair HFA 115-21 mcg inhalers. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- This is a $16,117.61 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,062,247 units of the prescription medication Advair HFA 115-21 MCG Inhaler 12GM. The award has an ultimate completion date of April 29, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,990.96, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 4, 2025. This delivery order is part of a larger...
- This is a $33,294.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Advair HFA 230-21 mcg inhalers, a brand-name respiratory medication, with a period of performance through July 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,990.48 firm fixed price contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication used to treat asthma and COPD. This delivery order is against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999 through December 2025, for providing...
- This federal contract award, valued at $1,207.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler (12GM), a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a firm-fixed-price delivery order with an ultimate completion date of August 15, 2024. Amerisourcebergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,183.96 firm-fixed-price contract is for the supply of Advair HFA 115-21 MCG inhalers. The contract has an ultimate completion date of March 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY7PKDelivery Order
This is a $11,190.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 115-21 mcg inhalers, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 5/29/24 |